Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients

Research output: Contribution to journalReview articlepeer-review

165 Scopus citations

Fingerprint

Dive into the research topics of 'Safety of combination interferon alfa-2b/ribavirin therapy in chronic hepatitis C-relapsed and treatment-naive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences